Paraneoplastic Encephalomyelitis: Diagnosis
The question
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 27 May to Question 51941 on Paraneoplastic Encephalomyelitis: Diagnosis, if his Department will write to the laboratories that do provide testing for the condition and ask whether they provide testing for KLHL11 antibodies.
Answered by Ashley Dalton
There are no current plans to write to laboratories that provide testing for paraneoplastic encephalomyelitis to ask whether this includes KLHl11 antibody testing.
27 pathology networks across England are working to provide a vast range of tests to ensure the accurate and timely diagnosis of conditions. This includes those tests that are typically used to support the diagnosis of paraneoplastic encephalomyelitis, such as immunology tests.
The Government is supporting pathology networks to increase digital capabilities by March 2026 to reduce unnecessary waits and repeat tests, to ensure that patients receive their results sooner. This is supported by £600 million of capital in 2025/26 for diagnostics. This investment also provides funding for the automation of histopathology laboratories.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →